Publications by authors named "Deepender Kaushik"

Claim this Profile
D
Dual immunomodulatory and antileishmanial potential of TLR7/8 agonists against .
Shivani Thakur, Deepender Kaushik, Kushvinder Kumar, Sandeep Kaur, Ravinder Kumar

Infect Immun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationship of Antischistosomal Aryl Hydantoin (AR102).
Derek A Leas, Cécile Häberli, Karen L White, David M Shackleford, Jeremy O Jones, Deepender Kaushik

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1)-Pyridones, 4(1)-Quinolones, and 9(10)-Acridones.
Rongguo Ren, Longjin Zhong, Cassandra Noack, Deepender Kaushik, Derek A Leas

ACS Med Chem Lett· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Triazolo[4',5':4,5]furo[2,3-]pyridine via Post Modification of an Unusual Groebke-Blackburn-Bienaymé Multicomponent Reaction.
Aashima Batra, Manpreet Kaur, Deepender Kaushik, Simran Kaur, Madhuri T Patil

ACS Omega· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist.
Deepender Kaushik, Arshpreet Kaur, Madhuri T Patil, Binita Sihag, Sakshi Piplani

J Med Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoisomeric PamCS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants.
Arshpreet Kaur, Sakshi Piplani, Deepender Kaushik, Johnson Fung, Isaac G Sakala

RSC Med Chem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice.
Arshpreet Kaur, Rohini Kanwar, Deepender Kaushik, Isaac G Sakala, Yoshikazu Honda-Okubo

Int J Pharm· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent.
Deepender Kaushik, Juliana T Granato, Gilson C Macedo, Paula R B Dib, Sakshi Piplani

J Pharm Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.
Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, Deepak B Salunke

RSC Med Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects.
Arshpreet Kaur, Deepender Kaushik, Sakshi Piplani, Surinder K Mehta, Nikolai Petrovsky

J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant.
Deepender Kaushik, Simran Dhingra, Madhuri T Patil, Sakshi Piplani, Varun Khanna

Hum Vaccin Immunother· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host.
Ruchika Saroa, Deepender Kaushik, Upma Bagai, Sukhbir Kaur, Deepak B Salunke

Bioorg Med Chem Lett· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis